RESEARCHERS HOPE BLOOD TEST COULD DETECT CANCER

Researchers at Purdue University have developed a process to study blood that could open the door to detecting cancer in patients with a simple blood test.

While the complex procedure is years away from routine use, it could one day prove effective at early detection of cancer and early relapses, said W. Andy Tao, a professor of biochemistry at Purdue in West Lafayette, Ind., who led the work.

For now, Tao’s work has looked only at a small number of patients with breast cancer, but it could have implications for other cancers as well, said Timothy Ratliff, Robert Wallace Miller director of the Purdue University Center for Cancer Research.

“The exciting part is it’s a blood test that really offers the potential to detect many different diseases,” Ratliff said.

The work appeared earlier this week in an online early edition of the Proceedings of the National Academy of Sciences.

TURKISH CLIENT PAID $530,000 TO FLYNN’S FIRM

President Trump’s former national security adviser Michael Flynn earned $530,000 last fall for consulting work that may have helped benefit the government of Turkey, according to new federal filings.

Flynn, fired last month from his White House post, formally registered as a foreign agent this week with the Justice Department and disclosed the details of his work for Inovo BV, a Dutch consulting firm owned by a Turkish businessman with ties to Turkey’s President Recep Tayyip Erdogan.

Flynn’s lawyer Robert Kelner said Flynn shut down his firm last year, but decided to register because his work for Inovo BV “could be construed to have principally benefited the Republic of Turkey.”

The documents show Inovo wrote six-figure checks to Flynn’s firm in September and October as he served as a top national security aide on Trump’s campaign.